TARGET ONCOL - Targeted Oncology

Publications

  1. 2016
  2. A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

    Loupakis, F., Stein, A., Ychou, M., Hermann, F., Salud, A. & Österlund, P., 06.2016, In: TARGET ONCOL. 11, 3, p. 293-308

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition

    Liffers, K., Kolbe, K., Westphal, M., Lamszus, K. & Schulte, A., 01.02.2016, In: TARGET ONCOL. 11, 1, p. 29-40

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2014
  5. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer

    Vashist, Y. K., Trump, F., Gebauer, F., Kutup, A., Güngör, C., Kalinin, V., Muddasar, R., Vettorazzi, E., Yekebas, E. F., Brandt, B., Pantel, K. & Izbicki, J. R., 01.03.2014, In: TARGET ONCOL. 9, 1, p. 43-52 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2010
  7. Glioma stem cells as a target for treatment.

    Lamszus, K. & Günther, H., 2010, In: TARGET ONCOL. 5, 3, p. 211-215 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review